#Japan #Kyoto #Second Heart #FUNDINNO #Steplife

Second Heart Launches Equity Crowdfunding

In a significant move to address a critical health issue, Second Heart Co., headquartered in Kyoto, is set to kick off an equity crowdfunding campaign on July 14, 2026, using the popular platform FUNDINNO. The company, led by CEO Yukihiro Ishida, aims to eliminate cases of foot amputation due to diabetes, an urgent global challenge where approximately one person loses a foot every 20 seconds due to complications from this disease.

Details about the Equity Crowdfunding

The fundraising drive will be conducted via FUNDINNO, which specializes in equity-based crowdfunding, allowing individuals to invest in promising startups. Interested investors are encouraged to participate in one of six scheduled online sessions starting on July 13, where the company will provide comprehensive insights into the fundraising initiative and its associated business model. The funds raised are earmarked for the research and development of Second Heart's remote foot monitoring service, "Steplife," and for expanding its operations into the ASEAN markets, starting with Malaysia.

The Urgent Need for Solutions

Diabetes is affecting millions, with about 10 million patients in Japan alone. Diabetic foot problems can result in amputations, which severely impact the quality of life and prevent social participation. By monitoring foot health early and continuously, there's a high potential to prevent these grave outcomes. Second Heart believes in a proactive approach to healthcare, working toward a platform that connects patients, medical institutions, and social security systems to foster preventive care.

Innovations Like "Steplife"

Second Heart's flagship product, "Steplife," allows diabetic patients to capture images of their foot health and share them with healthcare professionals. This innovative cloud-based service facilitates daily self-checks and remote consultations, thereby enabling early detection of abnormalities and assisting clinicians in preventing severe complications. Additionally, the digital tuning fork, another of their medical devices, screens for peripheral nerve damage in just about 30 seconds. This significant reduction in testing time compared to traditional methods enhances both the efficiency of medical practices and the opportunities for early intervention.

Achievements So Far

Second Heart's journey has seen substantial milestones in establishing its business foundation domestically, alongside pursuing international collaborations and securing public support:

• - Domestic Penetration: Currently, 10 medical institutions have adopted "Steplife" for a fee, engaging approximately 1,400 registered patients, with quarterly revenue increasing nearly fourfold compared to the previous year.
• - International Expansion: The company signed a memorandum of cooperation (MoC) with the Malaysian social security organization (PERKESO), intending to reach up to 1 million diabetic patients through extensive public implementation after successful proof of concept (PoC).
• - Research Collaborations: A joint research agreement has been established with the Graduate School of Medicine at Kyoto University.
• - Recognitions: The company has received acknowledgments from governmental bodies and awards such as the Ministry of Internal Affairs and Communications' ICT Startup League.

The Financial Details

The crowdfunding initiative through FUNDINNO aims to raise a target amount of 498,750,000 Japanese yen. The funds will primarily go toward further development of the "Steplife" service and the digital tuning fork. Should they achieve the upper limit for investments, the additional funds will help cover personnel expenses and market expansion costs in ASEAN starting from Malaysia.

Upcoming Online Business Briefing

To facilitate potential investors, Six online briefing sessions will take place from July 13 to July 21. CEO Ishida will lead these presentations, explaining the business outlook and addressing questions from attendees. Each session aims to foster a deeper understanding of Second Heart's innovative approach to diabetes management and investment potential.

Join Second Heart in fighting against the epidemic of diabetic foot complications by participating in their crowdfunding campaign or attending the informative online sessions. Your involvement could play a vital role in preventing needless amputations and improving the quality of life for millions suffering from diabetes.

For more details, visit their FUNDINNO campaign page.

Company Overview

Second Heart Co., Ltd.

• - Location: 232-7 Odawara-cho, Shimogyo Ward, Kyoto, Japan.
• - CEO: Yukihiro Ishida
• - Website: www.secondheart.co.jp
• - Group Company: SECOND HEART ASIA Sdh. Bhd.

This represents a critical advance not only in medical technology but also in targeting pressing social needs. With your support, Second Heart can make a profound impact on diabetic patient care.